Alliance Pharma to be Acquired by Aegros Bidco

Deal News | Jan 14, 2025 | White & Case

Alliance Pharma to be Acquired by Aegros Bidco

Global law firm White & Case LLP has successfully advised payment-in-kind (PIK) creditors on both the debt and equity financing involved in the acquisition of Alliance Pharma plc. The acquisition of the UK listed international consumer healthcare company, valued at £350 million, is to be carried out by Aegros Bidco Limited, a company under the ownership of DBAY Advisors and Edmond de Rothschild Equity Opportunities IV SLP. Alliance Pharma, with headquarters in the UK, has an extensive network and market presence in over 100 countries, including major markets such as France, the US, Germany, and China. The PIK creditors for this transaction include Three Hills, a private investment firm managing €3 billion in assets, and Barings, an asset management firm with over US$430 billion under management. The White & Case advisory team involved key partners and associates from their London office.

Sectors

  • Legal Services
  • Private Equity
  • Healthcare
  • Asset Management

Geography

  • United Kingdom – Alliance Pharma is headquartered in the UK and is being acquired by UK-based entities.
  • Europe – The transaction involves European entities such as Three Hills and headquarters in UK/Europe.
  • North America – Three Hills Investment, one of the PIK creditors, operates in North America.

Industry

  • Legal Services – The involvement of White & Case LLP, a legal advisory firm, in providing legal advice to the PIK creditors in the acquisition deal.
  • Private Equity – DBAY Advisors and Edmond de Rothschild Equity are private equity entities involved in the acquisition of Alliance Pharma.
  • Healthcare – Alliance Pharma is a consumer healthcare company, indicating the deal's relevance to the healthcare industry.
  • Asset Management – Involvement of Barings, an asset management firm, as one of the PIK creditors in the transaction.

Financials

  • £350 million – The valuation of Alliance Pharma's entire issued share capital.
  • €3 billion – Assets under management by Three Hills.
  • US$430 billion – Assets under management by Barings.

Participants

NameRoleTypeDescription
White & Case LLPLegal AdvisorCompanyA global law firm advising PIK creditors on the acquisition deal.
Alliance Pharma plcTarget CompanyCompanyA UK-listed international consumer healthcare company being acquired.
Aegros Bidco LimitedBidding CompanyCompanyThe company acquiring Alliance Pharma, owned by DBAY Advisors and Edmond de Rothschild.
DBAY AdvisorsPrivate Equity FirmCompanyPart-owner of Aegros Bidco Limited involved in the acquisition.
Edmond de Rothschild Equity Opportunities IV SLPPrivate Equity FirmCompanyPart-owner of Aegros Bidco Limited involved in the acquisition.
Three HillsCreditorCompanyA private markets investment firm part of the PIK creditors.
BaringsCreditorCompanyA global asset management firm part of the PIK creditors.